[Funding alert] Paris-based Medical Device Company BCV Secures €6M in Series A Round Funding

The funds will be utilised by the company to expedite the development of its line of active mechatronic guidewires, from manufacturing to launch.

Read also - Swiss Startup PLAN-B NET ZERO Secures €9.2 Million in Series A Round Funding

BCV is a medical device firm led by Raphaël Blanc, M.D., Chairman, and CEO Thierry Col. Its mission is to enhance patient outcomes by offering endovascular procedure navigation that is optimised. The business filed a pre-submission application with the FDA and finished its first in-human clinical trial at the Rothschild Foundation Hospital in Paris in 2022.

The patented invention consists of a generator and an actuable guidewire that are managed by a smart handle. Shape-memory alloy technology in the BCV system allows for distal tip control, improving practitioners' motions and outperforming current sophisticated actuation technologies in terms of performance.

Read also - Belgian Sports Tech Startup Raw Stadia Secures €1.5 Million in Funding

The BCV System was initially developed as an experimental tool with assistance from INSERM (Paris, France) and the Institute of Intelligent Systems and Robotics (ISIR) at Sorbonne University-CNRS. It is not currently available for purchase somewhere else in the world.

About BCV

The Intelligent Robotic Systems Laboratory (ISIR) of Sorbonne University and the Rothschild Foundation Hospital in Paris are the governing institutions of Bcv, a French Medtech startup.

Read also - Zurich-based Climate Tech Metafuels Secures €7.4 Million in Funding

An interdisciplinary group creating cutting-edge technology for endovascular treatments with the goal of enhancing them now and using them in the future.